Coronary and carotid atherosclerosis: How useful is the imaging?

Atherosclerosis

Volumn 231, Issue 2, 2013, Pages 323-333

  Ibrahimi, Pranvera ^a   Jashari, Fisnik ^a   Nicoll, Rachel ^a   Bajraktari, Gani ^a   Wester, Per ^a   Henein, Michael Y ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

Arterial calcification; Atherosclerosis imaging; Dupplex ultrasound; Intravascular ultrasound; OCT

Indexed keywords

ATORVASTATIN; ROSUVASTATIN;

ANGIOCARDIOGRAPHY; ARTERIAL WALL THICKNESS; ATHEROSCLEROTIC PLAQUE; BLEEDING; CARDIOVASCULAR MAGNETIC RESONANCE; CAROTID ARTERY OBSTRUCTION; CAROTID ATHEROSCLEROSIS; CAROTID ENDARTERECTOMY; CEREBROVASCULAR ACCIDENT; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONVENTIONAL ANGIOGRAPHY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY CALCIUM SCORE; DIAGNOSTIC IMAGING; DRUG EFFECT; HUMAN; HYPERCHOLESTEROLEMIA; INTRAVASCULAR ULTRASOUND; NEOVASCULARIZATION (PATHOLOGY); NUCLEAR MAGNETIC RESONANCE IMAGING; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; TRANSIENT ISCHEMIC ATTACK;

ARTERIAL CALCIFICATION; ATHEROSCLEROSIS IMAGING; DUPPLEX ULTRASOUND; INTRAVASCULAR ULTRASOUND; OCT;

ANGIOGRAPHY; CALCINOSIS; CALCIUM; CAROTID ARTERY DISEASES; CORONARY ARTERY DISEASE; CORONARY VESSELS; HUMANS; INFLAMMATION; MAGNETIC RESONANCE IMAGING; NEOVASCULARIZATION, PATHOLOGIC; PLAQUE, ATHEROSCLEROTIC; RISK; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY;

EID: 84888117132     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2013.09.035     Document Type: Review

References (150)

1. Jashari F., Ibrahimi P., Nicoll R., Bajraktari G., Wester P., Henein M.Y. Coronary and carotid atherosclerosis: similarities and differences. Atherosclerosis 2013, 227(2):193-200.
2. Hellings W.E., Peeters W., Moll F.L., Pasterkamp G. From vulnerable plaque to vulnerable patient: the search for biomarkers of plaque destabilization. Trends Cardiovasc Med 2007, 17(5):162-171.
3. Hackett D., Davies G., Maseri A. Pre-existing coronary stenoses in patients with first myocardial infarction are not necessarily severe. Eur Heart J 1988, 9(12):1317-1323.
4. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994, 344(8934):1383-1389.
5. Corti R., Fayad Z.A., Fuster V., et al. Effects of lipid-lowering by simvastatin on human atherosclerotic lesions: a longitudinal study by high-resolution, noninvasive magnetic resonance imaging. Circulation 2001, 104(3):249-252.
6. Glagov S., Weisenberg E., Zarins C.K., Stankunavicius R., Kolettis G.J. Compensatory enlargement of human atherosclerotic coronary arteries. NEngl J Med 1987, 316(22):1371-1375.
7. Nissen S.E., Gurley J.C., Grines C.L., et al. Intravascular ultrasound assessment of lumen size and wall morphology in normal subjects and patients with coronary artery disease. Circulation 1991, 84(3):1087-1099.
8. Kubo T., Imanishi T., Takarada S., et al. Assessment of culprit lesion morphology in acute myocardial infarction: ability of optical coherence tomography compared with intravascular ultrasound and coronary angioscopy. JAm Coll Cardiol 2007, 50(10):933-939.
9. Honda O., Sugiyama S., Kugiyama K., et al. Echolucent carotid plaques predict future coronary events in patients with coronary artery disease. JAm Coll Cardiol 2004, 43(7):1177-1184.
10. Rothwell P.M., Villagra R., Gibson R., Donders R.C., Warlow C.P. Evidence of a chronic systemic cause of instability of atherosclerotic plaques. Lancet 2000, 355(9197):19-24.
11. Chen W.Q., Zhang M., Ji X.P., et al. Usefulness of high-frequency vascular ultrasound imaging and serum inflammatory markers to predict plaque rupture in patients with stable and unstable angina pectoris. Am J Cardiol 2007, 100(9):1341-1346.
12. O'Leary D.H., Polak J.F., Kronmal R.A., Manolio T.A., Burke G.L., Wolfson S.K. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. Engl J Med 1999, 340(1):14-22.
13. Vancraeynest D., Pasquet A., Roelants V., Gerber B.L., Vanoverschelde J.L. Imaging the vulnerable plaque. JAm Coll Cardiol 2011, 57(20):1961-1979.
14. Wikstrand J. Methodological considerations of ultrasound measurement of carotid artery intima-media thickness and lumen diameter. Clin Physiol Funct Imaging 2007, 27(6):341-345.
15. Chambless L.E., Heiss G., Folsom A.R., et al. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. Am J Epidemiol 1997, 146(6):483-494.
16. Nambi V., Chambless L., Folsom A.R., et al. Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk: the ARIC (Atherosclerosis Risk in Communities) study. JAm Coll Cardiol 2010, 55(15):1600-1607.
17. Crouse J.R., Raichlen J.S., Riley W.A., et al. METEOR Study Group. Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial. JAMA 2007, 297(12):1344-1353.
18. Amarenco P., Labreuche J., Lavallée P., Touboul P.J. Statins in stroke prevention and carotid atherosclerosis: systematic review and up-to-date meta-analysis. Stroke 2004, 35(12):2902-2909.
19. Smilde T.J., van Wissen S., Wollersheim H., Trip M.D., Kastelein J.J., Stalenhoef A.F. Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP): a prospective, randomised, double-blind trial. Lancet 2001, 357(9256):577-581.
20. Lorenz M.W., Polak J.F., Kavousi M., et al. Carotid intima-media thickness progression to predict cardiovascular events in the general population (the PROG-IMT collaborative project): a meta-analysis of individual participant data. Lancet 2012, 379(9831):2053-2062.
21. Rundek T., Blanton S.H., Bartels S., et al. Traditional risk factors are not major contributors to the variance in carotid intima-media thickness. Stroke 2013, 44(8):2101-2108.
22. den Ruijter H.M., Peters S.A., Groenewegen K.A., et al. Common carotid intima-media thickness does not add to Framingham risk score in individuals with diabetes mellitus: the USE-IMT initiative. Diabetologia 2013, 56(7):1494-1502.
23. Spence J.D., Eliasziw M., DiCicco M., Hackam D.G., Galil R., Lohmann T. Carotid plaque area: a tool for targeting and evaluating vascular preventive therapy. Stroke 2002, 33(12):2916-2922.
24. Ebrahim S., Papacosta O., Whincup P., et al. Carotid plaque, intima media thickness, cardiovascular risk factors, and prevalent cardiovascular disease in men and women: the British Regional Heart Study. Stroke 1999, 30(4):841-850.
25. Bots M.L., Hoes A.W., Koudstaal P.J., Hofman A., Grobbee D.E. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation 1997, 96(5):1432-1437.
26. Wannarong T., Parraga G., Buchanan D., et al. Progression of carotid plaque volume predicts cardiovascular events. Stroke 2013, 44(7):1859-1865.
27. McEvoy J.W., Nasir K., Blumenthal R.S. Calcium score reclassification: how should baseline risk be measured?. JAm Coll Cardiol 2011, 57(24):2456-2457.
28. Budoff M.J., Young R., Lopez V.A., et al. Progression of coronary calcium and incident coronary heart disease events: MESA (Multi-Ethnic Study of Atherosclerosis). JAm Coll Cardiol 2013, 61(12):1231-1239.
29. Polonsky T.S., McClelland R.L., Jorgensen N.W., et al. Coronary artery calcium score and risk classification for coronary heart disease prediction. JAMA 2010, 303(16):1610-1616.
30. Taylor A.J., Bindeman J., Le T.P., et al. Progression of calcified coronary atherosclerosis: relationship to coronary risk factors and carotid intima-mediathickness. Atherosclerosis 2008, 197(1):339-345.
31. Folsom A.R., Kronmal R.A., Detrano R.C., et al. Coronary artery calcification compared with carotid intima-media thickness in the prediction of cardiovascular disease incidence: the Multi-Ethnic Study of Atherosclerosis (MESA). Arch Intern Med 2008, 168(12):1333-1339.
32. Gallino A., Stuber M., Crea F., et al. "Invivo" imaging of atherosclerosis. Atherosclerosis 2012, 224(1):25-36.
33. Erbel R., Möhlenkamp S., Moebus S. Coronary risk stratification, discrimination, and reclassification improvement based on quantification of subclinical coronary atherosclerosis: the Heinz Nixdorf Recall study. JAm Coll Cardiol 2010, 56(17):1397-1406. Heinz Nixdorf Recall Study Investigative Group.
34. Schenker M.P., Dorbala S., Hong E.C., et al. Interrelation of coronary calcification, myocardial ischemia, and outcomes in patients with intermediate likelihood of coronary artery disease: a combined positron emission tomography/computed tomography study. Circulation 2008, 117(13):1693-1700.
35. Henneman M.M., Schuijf J.D., Pundziute G., et al. Noninvasive evaluation with multislice computed tomography in suspected acute coronary syndrome: plaque morphology on multislice computed tomography versus coronary calcium score. JAm Coll Cardiol 2008, 52(3):216-222.
36. Rosen B.D., Fernandes V., McClelland R.L., et al. Relationship between baseline coronary calcium score and demonstration of coronary artery stenoses during follow-up MESA (Multi-Ethnic Study of Atherosclerosis). JACC Cardiovasc Imaging 2009, 2(10):1175-1183.
37. Iwasaki K., Matsumoto T., Aono H., Furukawa H., Samukawa M. Prevalence of subclinical atherosclerosis in asymptomatic patients with low-to-intermediate risk by 64-slice computed tomography. Coron Artery Dis 2011, 22(1):18-25.
38. Nakanishi K., Fukuda S., Shimada K., et al. Non-obstructive low attenuation coronary plaque predicts three-year acute coronary syndrome events in patients with hypertension: multidetector computed tomographic study. JCardiol 2012, 59(2):167-175.
39. Teng Z., Degnan A.J., Sadat U., et al. Characterization of healing following atherosclerotic carotid plaque rupture in acutely symptomatic patients: an exploratory study using invivo cardiovascular magnetic resonance. JCardiovasc Magn Reson 2011, 13:64.
40. Koole D., Heyligers J., Moll F.L., Pasterkamp G. Intraplaque neovascularization and hemorrhage: markers for cardiovascular risk stratification and therapeutic monitoring. JCardiovasc Med (Hagerstown) 2012, 13(10):635-639.
41. Hellings W.E., Peeters W., Moll F.L., et al. Composition of carotid atherosclerotic plaque is associated with cardiovascular outcome: a prognostic study. Circulation 2010, 121(17):1941-1950.
42. Nicoll R., Henein M.Y. Arterial calcification: friend or foe?. Int J Cardiol 2013, 167(2):322-327.
43. Rinehart S., Vazquez G., Qian Z., Murrieta L., Christian K., Voros S. Quantitative measurements of coronary arterial stenosis, plaque geometry, and composition are highly reproducible with a standardized coronary arterial computed tomographic approach in high-quality CT datasets. JCardiovasc Comput Tomogr 2011, 5(1):35-43.
44. Achenbach S., Ropers D., Hoffmann U., et al. Assessment of coronary remodeling in stenotic and nonstenotic coronary atherosclerotic lesions by multidetector spiral computed tomography. JAm Coll Cardiol 2004, 43(5):842-847.
45. Matsuo Y., Takumi T., Mathew V., et al. Plaque characteristics and arterial remodeling in coronary and peripheral arterial systems. Atherosclerosis 2012, 223(2):365-371.
46. Virmani R., Kolodgie F.D., Burke A.P., Farb A., Schwartz S.M. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2000, 20(5):1262-1275.
47. Hayashi K., Mani V., Nemade A., et al. Variations in atherosclerosis and remodeling patterns in aorta and carotids. JCardiovasc Magn Reson 2010, 12:10.
48. Motoyama S., Sarai M., Inoue K., et al. Morphologic and functional assessment of coronary artery disease-potential application of computed tomography angiography and myocardial perfusion imaging. Circ J 2013, 77(2):411-417.
49. Kitagawa T., Yamamoto H., Horiguchi J., et al. Characterization of noncalcified coronary plaques and identification of culprit lesions in patients with acute coronary syndrome by 64-slice computed tomography. JACC Cardiovasc Imaging 2009, 2(2):153-160.
50. Takeuchi H., Morino Y., Matsukage T., et al. Impact of vascular remodeling on the coronary plaque compositions: an investigation with invivo tissue characterization using integrated backscatter-intravascular ultrasound. Atherosclerosis 2009, 202(2):476-482.
51. Kröner E.S., van Velzen J.E., Boogers M.J., et al. Positive remodeling on coronary computed tomography as a marker for plaque vulnerability on virtual histology intravascular ultrasound. Am J Cardiol 2011, 107(12):1725-1729.
52. Stone G.W., Maehara A., Lansky A.J., et al. Aprospective natural-history study of coronary atherosclerosis. NEngl J Med 2011, 364(3):226-235. PROSPECT Investigators.
53. Hardie A.D., Kramer C.M., Raghavan P., Baskurt E., Nandalur K.R. The impact of expansive arterial remodeling on clinical presentation in carotid artery disease: a multidetector CT angiography study. AJNR Am J Neuroradiol 2007, 28(6):1067-1070.
54. Ballantyne C.M., Raichlen J.S., Nicholls S.J., et al. Effect of rosuvastatin therapy on coronary artery stenoses assessed by quantitative coronary angiography: a study to evaluate the effect of rosuvastatin on intravascular ultrasound-derived coronary atheroma burden. Circulation 2008, 117(19):2458-2466. ASTEROID Investigators.
55. Nissen S.E., Tuzcu E.M., Schoenhagen P., et al. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. JAMA 2004, 291:1071-1080.
56. von Birgelen C., Hartmann M., Mintz G.S., Baumgart D., Schmermund A., Erbel R. Relation between progression and regression of atherosclerotic left main coronary artery disease and serum cholesterol levels as assessed with serial long-term (> or=12 months) follow-up intravascular ultrasound. Circulation 2003, 108(22):2757-2762.
57. Lee C.W., Kang S.J., Ahn J.M., et al. Comparison of effects of atorvastatin (20 mg) versus rosuvastatin (10 mg) therapy on mild coronary atherosclerotic plaques (from the ARTMAP trial). Am J Cardiol 2012, 109(12):1700-1704.
58. Inoue K., Motoyama S., Sarai M., et al. Serial coronary CT angiography-verified changes in plaque characteristics as an end point: evaluation of effect of statin intervention. JACC Cardiovasc Imaging 2010, 3(7):691-698.
59. Waxman S., Mittleman M.A., Zarich S.W., et al. Plaque disruption and thrombus in Ambrose's angiographic coronary lesion types. Am J Cardiol 2003, 92(1):16-20.
60. Kitamura A., Iso H., Imano H., et al. Carotid intima-media thickness and plaque characteristics as a risk factor for stroke in Japanese elderly men. Stroke 2004, 35:2788-2794.
61. Prabhakaran S., Rundek T., Ramas R., et al. Carotid plaque surface irregularity predicts ischemic stroke: the northern Manhattan study. Stroke 2006, 37(11):2696-2701.
62. Saba L., Caddeo G., Sanfilippo R., Montisci R., Mallarini G. CT and ultrasound in the study of ulcerated carotid plaque compared with surgical results: potentialities and advantages of multidetector row CT angiography. AJNR Am J Neuroradiol 2007, 28(6):1061-1066.
63. Ten Kate G.L., van Dijk A.C., van den Oord S.C., et al. Usefulness of contrast-enhanced ultrasound for detection of carotid plaque ulceration in patients with symptomatic carotid atherosclerosis. Am J Cardiol 2013, 112(2):292-298.
64. Redgrave J.N., Lovett J.K., Gallagher P.J., Rothwell P.M. Histological assessment of 526 symptomatic carotid plaques in relation to the nature and timing of ischemic symptoms: the Oxford plaque study. Circulation 2006, 113(19):2320-2328.
65. Li Z.Y., Howarth S.P., Tang T., Gillard J.H. How critical is fibrous cap thickness to carotid plaque stability? A flow-plaque interaction model. Stroke 2006, 37(5):1195-1199.
66. Takaya N., Yuan C., Chu B., et al. Association between carotid plaque characteristics and subsequent ischemic cerebrovascular events: a prospective assessment with MRI-initial results. Stroke 2006, 37(3):818-823.
67. Libby P. Inflammation in atherosclerosis. Nature 2002, 420(6917):868-874.
68. Cassar A., Matsuo Y., Herrmann J. Coronary atherosclerosis with vulnerable plaque and complicated lesions in transplant recipients: new insight into cardiac allograft vasculopathy by optical coherence tomography. Eur Heart J 2013, 34(33):2610-2617.
69. Larose E., Kinlay S., Selwyn A.P., et al. Improved characterization of atherosclerotic plaques by gadolinium contrast during intravascular magnetic resonance imaging of human arteries. Atherosclerosis 2008, 196(2):919-925.
70. Sano K., Kawasaki M., Ishihara Y., et al. Assessment of vulnerable plaques causing acute coronary syndrome using integrated backscatter intravascular ultrasound. JAm Coll Cardiol 2006, 47(4):734-741.
71. Virmani R., Burke A.P., Farb A., Kolodgie F.D. Pathology of the vulnerable plaque. JAm Coll Cardiol 2006, 47(Suppl.8):C13-C18.
72. AbuRahma A.F., Kyer P.D., Robinson P.A., Hannay R.S. The correlation of ultrasonic carotid plaque morphology and carotid plaque hemorrhage: clinical implications. Surgery 1998, 124(4):721-726. discussion 726-8.
73. Tegos T.J., Sohail M., Sabetai M.M., et al. Echomorphologic and histopathologic characteristics of unstable carotid plaques. AJNR Am J Neuroradiol 2000, 21(10):1937-1944.
74. Grønholdt M.L., Wiebe B.M., Laursen H., Nielsen T.G., Schroeder T.V., Sillesen H. Lipid-rich carotid artery plaques appear echolucent on ultrasound B-mode images and may be associated with intraplaque haemorrhage. Eur J Vasc Endovasc Surg 1997, 14(6):439-445.
75. Palmer N.D., Northridge D., Lessells A., McDicken W.N., Fox K.A. Invitro analysis of coronary atheromatous lesions by intravascular ultrasound; reproducibility and histological correlation of lesion morphology. Eur Heart J 1999, 20(23):1701-1706.
76. König A., Margolis M.P., Virmani R., Holmes D., Klauss V. Technology insight: invivo coronary plaque classification by intravascular ultrasonography radiofrequency analysis. Nat Clin Pract Cardiovasc Med 2008, 5(4):219-229.
77. Nasu K., Tsuchikane E., Katoh O., et al. Accuracy of invivo coronary plaque morphology assessment: a validation study of invivo virtual histology compared with invitro histopathology. JAm Coll Cardiol 2006, 47(12):2405-2412.
78. Kawasaki M., Sano K., Okubo M., et al. Volumetric quantitative analysis of tissue characteristics of coronary plaques after statin therapy using three-dimensional integrated backscatter intravascular ultrasound. JAm Coll Cardiol 2005, 45(12):1946-1953.
79. Serruys P.W., García-García H.M., Buszman P., et al. Effects of the direct lipoprotein-associated phospholipase A(2) inhibitor darapladib on human coronary atherosclerotic plaque. Circulation 2008, 118(11):1172-1182.
80. Schroeder S., Kopp A.F., Baumbach A., et al. Noninvasive detection and evaluation of the atherosclerotic plaque with multislice computed tomography. JAm Coll Cardiol 2001, 37:1430-1435.
81. Saba L., Argiolas G.M., Siotto P., Piga M. Carotid artery plaque characterization using CT multienergy imaging. AJNR Am J Neuroradiol 2013, 34(4):855-859.
82. Claessen B.E., Maehara A., Fahy M., Xu K., Stone G.W., Mintz G.S. Plaque composition by intravascular ultrasound and distal embolization after percutaneous coronary intervention. JACC Cardiovasc Imaging 2012, 5(Suppl.3):S111-S118.
83. Sztajzel R., Momjian-Mayor I., Comelli M., Momjian S. Correlation of cerebrovascular symptoms and microembolic signals with the stratified gray-scale median analysis and color mapping of the carotid plaque. Stroke 2006, 37(3):824-829.
84. Della-Morte D., Moussa I., Elkind M.S., et al. The short-term effect of atorvastatin on carotid plaque morphology assessed by computer-assisted gray-scale densitometry: a pilot study. Neurol Res 2011, 33(9):991-994.
85. Biasi G.M., Froio A., Diethrich E.B., et al. Carotid plaque echolucency increases the risk of stroke in carotid stenting: the Imaging in Carotid Angioplasty and Risk of Stroke (ICAROS) study. Circulation 2004, 110(6):756-762. Epub 2004 Jul 26.
86. Sluimer J.C., Gasc J.M., van Wanroij J.L., et al. Hypoxia, hypoxia-inducible transcription factor, and macrophages in human atherosclerotic plaques are correlated with intraplaque angiogenesis. JAm Coll Cardiol 2008, 51(13):1258-1265.
87. Virmani R., Kolodgie F.D., Burke A.P., et al. Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arterioscler Thromb Vasc Biol 2005, 25(10):2054-2061.
88. Mughal M.M., Khan M.K., DeMarco J.K., Majid A., Shamoun F., Abela G.S. Symptomatic and asymptomatic carotid artery plaque. Expert Rev Cardiovasc Ther 2011, 9(10):1315-1330.
89. Vavuranakis M., Kakadiaris I.A., O'Malley S.M., et al. Anew method for assessment of plaque vulnerability based on vasa vasorum imaging, by using contrast-enhanced intravascular ultrasound and differential image analysis. Int J Cardiol 2008, 130(1):23-29.
90. Kato K., Yonetsu T., Kim S.J., et al. Nonculprit plaques in patients with acute coronary syndromes have more vulnerable features compared with those with non-acute coronary syndromes: a 3-vessel optical coherence tomography study. Circ Cardiovasc Imaging 2012, 5(4):433-440.
91. Sirol M., Moreno P.R., Purushothaman K.R., et al. Increased neovascularization in advanced lipid-rich atherosclerotic lesions detected by gadofluorine-M-enhanced MRI: implications for plaque vulnerability. Circ Cardiovasc Imaging 2009, 2(5):391-396.
92. Fleiner M., Kummer M., Mirlacher M., et al. Arterial neovascularization and inflammation in vulnerable patients: early and late signs of symptomaticatherosclerosis. Circulation 2004, 110(18):2843-2850.
93. Staub D., Schinkel A.F., Coll B., et al. Contrast-enhanced ultrasound imaging of the vasa vasorum: from early atherosclerosis to the identification of unstable plaques. JACC Cardiovasc Imaging 2010, 3(7):761-771.
94. Coli S., Magnoni M., Sangiorgi G., et al. Contrast-enhanced ultrasound imaging of intraplaque neovascularization in carotid arteries: correlation with histology and plaque echogenicity. JAm Coll Cardiol 2008, 52(3):223-230.
95. Yang H., Xiong X., Zhang L., Wu C., Liu Y. Adhesion of bio-functionalized ultrasound microbubbles to endothelial cells by targeting to vascular cell adhesion molecule-1 under shear flow. Int J Nanomedicine 2011, 6:2043-2051.
96. Ten Kate G.L., van den Oord S.C., Sijbrands E.J., et al. Current status and future developments of contrast-enhanced ultrasound of carotid atherosclerosis. JVasc Surg 2013, 57(2):539-546.
97. Xiong L., Deng Y.B., Zhu Y., Liu Y.N., Bi X.J. Correlation of carotid plaque neovascularization detected by using contrast-enhanced US with clinical symptoms. Radiology 2009, 251(2):583-589.
98. Kockx M.M., Cromheeke K.M., Knaapen M.W., et al. Phagocytosis and macrophage activation associated with hemorrhagic microvessels in human atherosclerosis. Arterioscler Thromb Vasc Biol 2003, 23(3):440-446.
99. Huang X., Teng Z., Canton G., Ferguson M., Yuan C., Tang D. Intraplaque hemorrhage is associated with higher structural stresses in human atherosclerotic plaques: an invivo MRI-based 3D fluid-structure interaction study. Biomed Eng Online 2010, 9:86.
100. Takaya N., Yuan C., Chu B., et al. Presence of intraplaque hemorrhage stimulates progression of carotid atherosclerotic plaques: a high-resolution magnetic resonance imaging study. Circulation 2005, 111(21):2768-2775.
101. Cai J., Hatsukami T.S., Ferguson M.S., et al. Invivo quantitative measurement of intact fibrous cap and lipid-rich necrotic core size in atherosclerotic carotid plaque: comparison of high-resolution, contrast-enhanced magnetic resonance imaging and histology. Circulation 2005, 112(22):3437-3444.
102. Kurosaki Y., Yoshida K., Endo H., Chin M., Yamagata S. Association between carotid atherosclerosis plaque with high signal intensity on T1-weighted imaging and subsequent ipsilateral ischemic events. Neurosurgery 2011, 68(1):62-67. discussion 67.
103. Altaf N., Goode S.D., Beech A., et al. Plaque hemorrhage is a marker of thromboembolic activity in patients with symptomatic carotid disease. Radiology 2011, 258(2):538-545.
104. Sheikine Y., Akram K. FDG-PET imaging of atherosclerosis: do we know what we see?. Atherosclerosis 2010, 211(2):371-380.
105. Kelloff G.J., Hoffman J.M., Johnson B., et al. Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development. Clin Cancer Res 2005, 11(8):2785-2808.
106. Rudd J.H., Warburton E.A., Fryer T.D. Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography. Circulation 2002, 105(23):2708-2711.
107. Pedersen S.F., Graebe M., Fisker Hag A.M., Højgaard L., Sillesen H., Kjaer A. Gene expression and 18FDG uptake in atherosclerotic carotid plaques. Nucl Med Commun 2010, 31(5):423-429.
108. Ogawa M., Ishino S., Mukai T., et al. (18)F-FDG accumulation in atherosclerotic plaques: immunohistochemical and PET imaging study. JNucl Med 2004, 45(7):1245-1250.
109. Silvera S.S., Aidi H.E., Rudd J.H., et al. Multimodality imaging of atherosclerotic plaque activity and composition using FDG-PET/CT and MRI in carotid and femoral arteries. Atherosclerosis 2009, 207(1):139-143.
110. Moustafa R.R., Izquierdo-Garcia D., Fryer T.D., et al. Carotid plaque inflammation is associated with cerebral microembolism in patients with recent transient ischemic attack or stroke: a pilot study. Circ Cardiovasc Imaging 2010, 3(5):536-541.
111. Lederman R.J., Raylman R.R., Fisher S.J., et al. Detection of atherosclerosis using a novel positron-sensitive probe and 18-fluorodeoxyglucose (FDG). Nucl Med Commun 2001, 22(7):747-753.
112. Matter C.M., Wyss M.T., Meier P., et al. 18F-choline images murine atherosclerotic plaques exvivo. Arterioscler Thromb Vasc Biol 2006, 26(3):584-589.
113. Folco E.J., Sheikine Y., Rocha V.Z., et al. Hypoxia but not inflammation augments glucose uptake in human macrophages: implications for imaging atherosclerosis with 18fluorine-labeled 2-deoxy-D-glucose positron emission tomography. JAm Coll Cardiol 2011, 58(6):603-614.
114. Owen D.R., Shalhoub J., Miller S., et al. Inflammation within carotid atherosclerotic plaque: assessment with late-phase contrast-enhanced US. Radiology 2010, 255(2):638-644.
115. Verhoeven B.A., Moll F.L., Koekkoek J.A., et al. Statin treatment is not associated with consistent alterations in inflammatory status of carotid atherosclerotic plaques: a retrospective study in 378 patients undergoing carotid endarterectomy. Stroke 2006, 37(8):2054-2060.
116. Joshi F.R., Lindsay A.C., Obaid D.R., Falk E., Rudd J.H. Non-invasive imaging of atherosclerosis. Eur Heart J Cardiovasc Imaging 2012, 13(3):205-218.
117. Gaemperli O., Shalhoub J., Owen D.R., et al. Imaging intraplaque inflammation in carotid atherosclerosis with 11C-PK11195 positron emission tomography/computed tomography. Eur Heart J 2012, 33(15):1902-1910.
118. Rominger A., Saam T., Vogl E., et al. Invivo imaging of macrophage activity in the coronary arteries using 68Ga-DOTATATE PET/CT: correlation with coronary calcium burden and risk factors. JNucl Med 2010, 51(2):193-197.
119. Teräs M., Kokki T., Durand-Schaefer N., et al. Dual-gated cardiac PET-clinical feasibility study. Eur J Nucl Med Mol Imaging 2010, 37(3):505-516.
120. Wykrzykowska J., Lehman S., Williams G., et al. Imaging of inflamed and vulnerable plaque in coronary arteries with 18F-FDG PET/CT in patients with suppression of myocardial uptake using a low-carbohydrate, high-fat preparation. JNucl Med 2009, 50(4):563-568.
121. Tawakol A., Fayad Z.A., Mogg R., et al. Intensification of statin therapy results in a rapid reduction in atherosclerotic inflammation: results of a multicenter fluorodeoxyglucose-positron emission tomography/computed tomography feasibility study. JAm Coll Cardiol 2013, 62(10):909-917.
122. Saremi A., Anderson R.J., Luo P., et al. Association between IL-6 and the extent of coronary atherosclerosis in the veterans affairs diabetes trial (VADT). Atherosclerosis 2009, 203(2):610-614.
123. Moe S.M., Chen N.X. Inflammation and vascular calcification. Blood Purif 2005, 23(1):64-71.
124. Doherty T.M., Asotra K., Fitzpatrick L.A. Calcification in atherosclerosis: bone biology and chronic inflammation at the arterial crossroads. Proc Natl Acad Sci U S A 2003, 100(20):11201-11206.
125. Denzel C., Lell M., Maak M. Carotid artery calcium: accuracy of a calcium score by computed tomography-an invitro study with comparison to sonography and histology. Eur J Vasc Endovasc Surg 2004, 28(2):214-220.
126. van der Giessen A.G., Gijsen F.J. Small coronary calcifications are not detectable by 64-slice contrast enhanced computed tomography. Int J Cardiovasc Imaging 2011, 27(1):143-152.
127. Haimovici H. The role of arterial tissue susceptibility in atherogenesis. Tex Heart Inst J 1991, 18:81-83.
128. Virmani R., Ladich E.R., Burke A.P., Kolodgie F.D. Histopathology of carotid atherosclerotic disease. Neurosurgery 2006, 59(5 Suppl.3):S219-S227. discussion S3-13.
129. Wagenknecht L.E., Langefeld C.D., Freedman B.I., Carr J.J., Bowden D.W. Acomparison of risk factors for calcified atherosclerotic plaque in the coronary, carotid, and abdominal aortic arteries: the diabetes heart study. Am J Epidemiol 2007, 166(3):340-347.
130. Lee K.B., Budoff M.J., Zavodni A., et al. Coronary artery calcium is associated with degree of stenosis and surface irregularity of carotid artery. Atherosclerosis 2012, 223(1):160-165.
131. Knez A., Becker A., Leber A. Relation of coronary calcium scores by electron beam tomography to obstructive disease in 2,115 symptomatic patients. Am J Cardiol 2004, 93(9):1150-1152.
132. Greenland P., Bonow R.O., Brundage B.H., et al. ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography) developed in collaboration with the Society of Atherosclerosis Imaging and Prevention and the Society of Cardiovascular Computed Tomography. JAm Coll Cardiol 2007, 49(3):378-402.
133. Bajraktari G., Nicoll R., Ibrahimi P., Jashari F., Schmermund A., Henein M.Y. Coronary calcium score correlates with estimate of total plaque burden. Int J Cardiol 2012, pii: S0167-S5273 (12)01457-X.
134. Marquering H.A., Majoie C.B., Smagge L. The relation of carotid calcium volume with carotid artery stenosis in symptomatic patients. AJNR Am J Neuroradiol 2011, 32(7):1182-1187.
135. Arad Y., Goodman K.J., Roth M., Newstein D., Guerci A.D. Coronary calcification, coronary disease risk factors, C-reactive protein, and atherosclerotic cardiovascular disease events: the St. Francis Heart Study. JAm Coll Cardiol 2005, 46(1):158-165.
136. Detrano R., Guerci A.D., Carr J.J. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. NEngl J Med 2008, 358(13):1336-1345.
137. Hermann D.M., Gronewold J., Lehmann N., et al. Coronary artery calcification is an independent stroke predictor in the general population. Stroke 2013, 44(4):1008-1013.
138. de Weert T.T., Cakir H., Rozie S. Intracranial internal carotid artery calcifications: association with vascular risk factors and ischemic cerebrovascular disease. AJNR Am J Neuroradiol 2009, 30(1):177-184.
139. Prabhakaran S., Singh R., Zhou X., Ramas R., Sacco R.L., Rundek T. Presence of calcified carotid plaque predicts vascular events: the Northern Manhattan Study. Atherosclerosis 2007, 195(1):e197-e201.
140. Elias-Smale S.E., Wieberdink R.G., Odink A.E., et al. Burden of atherosclerosis improves the prediction of coronary heart disease but not cerebrovascular events: the Rotterdam Study. Eur Heart J 2011, 32(16):2050-2058.
141. Ciccone M.M., Marzullo A., Mizio D., et al. Can carotid plaque histology selectively predict the risk of an acute coronary syndrome?. Int Heart J 2011, 52(2):72-77.
142. Abedin M., Tintut Y., Demer L.L. Vascular calcification: mechanisms and clinical ramifications. Arterioscler Thromb Vasc Biol 2004, 24(7):1161-1170.
143. Alberts M.J., Bhatt D.L., Mas J.L., et al. Three-year follow-up and event rates in the international REduction of Atherothrombosis for Continued Health Registry. Eur Heart J 2009, 30:2318e26. Reduction of Atherothrombosis for Continued Health Registry Investigators.
144. Touzé E., Varenne O., Calvet D., Mas J.L. Coronary risk stratification in patientswith ischemic stroke or transient ischemic stroke attack. Int J Stroke 2007, 2(3):177e83.
145. Steinvil A., Sadeh B., Arbel Y., et al. Prevalence and predictors of concomitant carotid and coronary artery atherosclerotic disease. JAm Coll Cardiol 2011, 57(7):779e83.
146. Nair A., Kuban B.D., Tuzcu E.M., Schoenhagen P., Nissen S.E., Vince D.G. Coronary plaque classification with intravascular ultrasound radiofrequency data analysis. Circulation 2002, 106(17):2200-2206.
147. Yabushita H., Bouma B.E., Houser S.L., et al. Characterization of human atherosclerosis by optical coherence tomography. Circulation 2002, 106(13):1640-1645.
148. Larose E., Yeghiazarians Y., Libby P., et al. Characterization of human atherosclerotic plaques by intravascular magnetic resonance imaging. Circulation 2005, 112(15):2324-2331.
149. de Weert T.T., Ouhlous M., Meijering E., et al. Invivo characterization and quantification of atherosclerotic carotid plaque components with multidetector computed tomography and histopathological correlation. Arterioscler Thromb Vasc Biol 2006, 26(10):2366-2372.
150. Pundziute G., Schuijf J.D., Jukema J.W., et al. Evaluation of plaque characteristics in acute coronary syndromes: non invasive assessment with multi-slicecomputed tomography and invasive evaluation with intravascular ultrasound radiofrequency data analysis. Eur Heart J 2008, 29(19):2373-2381.